MORGAN STANLEY PLC/PUT/MEDTRONIC/70/0.1/20.06.25 Share Price

Warrant

DE000ME3H5E2

Market Closed - Börse Stuttgart 09:37:09 05/07/2024 pm IST
0.35 EUR +2.94% Intraday chart for MORGAN STANLEY PLC/PUT/MEDTRONIC/70/0.1/20.06.25
Current month+25.00%
1 month+48.31%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/24/05 0.35 +2.94%
04/24/04 0.34 0.00%
03/24/03 0.34 -5.56%
02/24/02 0.36 +12.50%
01/24/01 0.32 +14.29%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 09:37 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN ME3H5E
ISINDE000ME3H5E2
Date issued 13/11/2023
Strike 70 $
Maturity 20/06/2025 (349 Days)
Parity 10 : 1
Emission price 0.91
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.8
Lowest since issue 0.194
Delta-0.27x
Omega 5.424
Premium14.76x
Gearing20.17x
Moneyness 0.9019
Difference Strike -7.61 $
Difference Strike %-10.87%
Spread 0.01
Spread %2.78%
Theoretical value 0.3550
Implied Volatility 26.83 %
Total Loss Probability 64.07 %
Intrinsic value 0.000000
Present value 0.3550
Break even 66.15 €
Theta-0.01x
Vega0.02x
Rho-0.02x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.61 USD
Average target price
94.02 USD
Spread / Average Target
+21.15%
Consensus